Amniotic Membrane Market

Amniotic Membrane Market Size, Share, Growth Analysis, By Product(Cryopreserved, and Dehydrated), By Application(Surgical Wounds, Ophthalmology, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2086 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 62 | Figures: 75

Amniotic Membrane Market Dynamics

Amniotic Membrane Market Drivers

Growing Number of Reported Cases of Accidents  

  • Growing cases of workforce with extreme injuries while performing fieldwork is escalating the need for rapid and effective healing therapies. Amongst children and young adults, road accidents are the commonest causes of traumatic injuries. Road safety is being breached and traffic congestion is on the rise, pushing accident rates higher in countries around the world. Hence, in turn increasing the number of accident cases and trauma is supporting amniotic membrane market revenue.  

Increase in the Cases of Chronic and Acute Diseases  

  • Physical conditions, chronic diseases, affects the wound healing negatively. For example, obesity and diabetes can lead to more frequent occurrence of ulcers, such as leg and foot ulcers that would require wound therapy at sky-high costs. The increase in target medical procedures is expected to be driven by the growing adoption of amniotic products, which will largely depend on growth in the target patient population.  

Amniotic Membrane Market Restraints 

Expensive Amniotic Membrane Products  

  • The expense of amniotic goods along with solutions can be a main issue for affected individuals, suppliers, and also healthcare techniques. AMC products need biological specific processing and manufacture techniques to maintain their inherent properties while ensuring its safety. There is a lot of quality control, testing, and regulation compliance that needs to be managed through these processes — all of which adds to the cost of production.  

Unfavorable Regulatory and Reimbursement Policies  

  • The manufacture and distribution of drugs is governed by regulatory requirements as well as quality standards which increase the overall cost to manufacture and distribute. It takes resources and infrastructure to meet minimum regulatory standards and continue meeting them over time. Thus, obtaining reimbursement for these products and the treatment associated with them can be difficult. The extent of insurance coverage and reimbursement policy can differ, making it difficult to receive full reimbursement for these products and increasing the financial burden on patients and healthcare providers. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Amniotic Membrane Market size was valued at USD 3.90 Billion in 2023 and is poised to grow from USD 4.45 Billion in 2024 to USD 11.12 Billion by 2031, at a CAGR of 14% during the forecast period (2024-2031). 

The amniotic membrane market also has a high level of amniotic membrane industry concentration with few key market players. Rising applications in wound healing, ophthalmology and regenerative medicine are projected to drive the market. Regulatory frameworks also aid innovation by providing stringent standards, encouraging companies to derive new and innovative treatment options. Of course, regulations can inflate the cost and time of development, but they are imperative as they ultimately signal market credibility and growth. The dynamic nature of the amniotic membrane industry, along with a propensity for research and development, lead to increased mergers & acquisitions placed in the sector. M&A transactions allow companies to innovate their products and offer solutions that are more suited to the new era of healthcare professionals.  'MiMedx Group, Inc. (US)', 'TissueTech, Inc. (US)', 'Skye Biologics, Inc. (US)', 'Alliqua BioMedical, Inc. (US)', 'Amnio Technology, LLC (US)', 'Katena Products, Inc. (US)', 'Applied Biologics LLC (US)', 'Amniox Medical, Inc. (US)', 'Derma Sciences, Inc. (US)', 'Organogenesis Holdings Inc. (US)', 'Smith & Nephew plc (UK)', 'Integra LifeSciences Corporation (US)', 'Osiris Therapeutics, Inc. (US)', 'AmnioLife Corporation (US)', 'Human Regenerative Technologies, LLC (US)', 'AlloSource (US)', 'LifeCell International Pvt. Ltd. (India)', 'Amnion Life (US)', 'Surgenex (US)', 'NuVision Biotherapies Ltd. (UK)'

Growing cases of workforce with extreme injuries while performing fieldwork is escalating the need for rapid and effective healing therapies. Amongst children and young adults, road accidents are the commonest causes of traumatic injuries. Road safety is being breached and traffic congestion is on the rise, pushing accident rates higher in countries around the world. Hence, in turn increasing the number of accident cases and trauma is supporting amniotic membrane market revenue.  

Improving Healthcare Policies in Emerging Economies: Emerging nations like China, India, South Korea and Brazil, Mexico provide a potential growth opportunities due to less regulatory hurdles, improved healthcare infrastructure, ever-growing patient population and increasing healthcare expenditure. In addition, governance in the Asia Pacific remain much far more flexible as well as pro-business than developed nations around the world. Together with growing global competitiveness in established markets, this has attracted major players focused on emerging economies.  

In 2023, the overall global market for amniotic membrane was dominated by North America and generated the largest amniotic membrane market share across all regions. The growth in this region is primarily due to established healthcare infrastructure and leading players operating in the field. High availability of regenerative medicine and rising adoption of novel technologies is a major driver to bolster the amniotic membrane market growth across this region. Several key developments that support the use of amniotic membranes for ocular and wound healing treatments have helped continue this development. Moreover, supportive regulatory frameworks and ongoing investments into research & development bolster the market outlook for this segment over the forecast period. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Amniotic Membrane Market

Report ID: SQMIG35H2086

$5,300
BUY NOW GET FREE SAMPLE